In the heady days of 2021, central capital of the heart It planned to focus on consumer technology with a $200 million fund. If we move forward to 2024, its latest fund will now “leaven the bread” of that thesis, with a new $180 million (€170 million) to be broader and more generalist than the […]
MRIs are an indispensable tool for surgeons, although the technology certainly has its limitations. Take, for example, surgeons who use machines to guide their procedures. The current process involves placing the patient in a machine to obtain an image, before removing it to advance a needle one centimeter at a time. It’s a time-consuming and
MDC is building a surgical robot that operates inside an MRI– BC Read More »
Customers of genetic data outfit 23andMe may be at greater risk than they think, suggests a New York Times story That argues that the company’s problems could be short-lived compared to the long-term threats those roughly 15 million people face if 23andMe can’t continue as a going concern. Certainly, founder and CEO Anne Wojcicki’s hope
Future of 23andMe raises more concerns as genomic data analysis improves– Brit Commerce Read More »
23andMeThe personal genomics company, 23andMe, went public in early 2021 through a merger with a blank-check company that valued it at $3.5 billion. Then its fortunes began to sink. Declining interest in DNA kits (23andMe’s main product) was one of the factors driving it down. So was last year’s news that hackers stole ancestry data
23andMe sees independent board members resign en masse– Brit Commerce Read More »
As part of a new joint pilot programme with a UK startup Of beeAlphabet’s drone company To theand the UK’s National Health Service will soon use drones to transport urgent blood samples between two London hospitals. As part of the six-month pilot programme, drones will deliver urgently needed blood samples for surgical patients (at high
Londoners will soon see drones transporting blood between hospitals– Brit Commerce Read More »
